RETRACTED: The role of PKP1 in tumor progression in melanoma: Analysis of a cell adhesion‐related model
Environmental Toxicology · 2024
DOI: 10.1002/tox.24017 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Chao Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatologic Surgery, Hangzhou Third People's Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Research Foundation of Hangzhou Health Science and Technology Plan.
Abstract (Originalsprache)
The incidence rate of melanoma varies across regions, with Europe, the United States, and Australia having 10–25, 20–30, and 50–60 cases per 1 00 000 people. In China, patients with melanoma exhibit different clinical manifestations, pathogenesis, and outcomes. Current treatments include surgery, adjuvant therapy, and immune checkpoint inhibitors. Nonetheless, complications may arise during treatment. Melanoma development is heavily reliant on cell adhesion molecules (CAMs), and studying these molecules could provide new research directions for metastasis and progression. CAMs include the integrin, immunoglobulin, selectin, and cadherin families, and they affect multiple processes, such as maintenance, morphogenesis, and migration of adherens junction. In this study, a cell adhesion‐related risk prognostic signature was constructed using bioinformatics methods, and survival analysis was performed. Plakophilin 1 (PKP1) was observed to be crucial to the immune microenvironment and has significant effects on melanoma cell proliferation, migration, invasion, and the cell cycle. This signature demonstrates high reliability and has potential for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatologic Surgery, Hangzhou Third People's Hospital, Hangzhou, China.
- Department of Burns and Plastic & Wound Repair Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
- The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
- Dali University, Dali, China.
- China Medical University, Shenyang, China.
ORCID-Profile: Lingshan Qin
Förderung
- Research Foundation of Hangzhou Health Science and Technology Plan
Zitieren
APA
Yue, C., Lian, W., Fan, Z., Li, H., Duan, M., Qin, L., Cao, X., & Peng, J. (2024). RETRACTED: The role of PKP1 in tumor progression in melanoma: Analysis of a cell adhesion‐related model. Environmental Toxicology. https://doi.org/10.1002/tox.24017
Vancouver
Yue C, Lian W, Fan Z, Li H, Duan M, Qin L, et al. RETRACTED: The role of PKP1 in tumor progression in melanoma: Analysis of a cell adhesion‐related model. Environmental Toxicology. 2024. doi:10.1002/tox.24017
BibTeX
@article{Yue2024,
author = {Yue, Chao and Lian, Wenqin and Fan, Zhongru and Li, Haochen and Duan, Mengying and Qin, Lingshan and Cao, Xianbin and Peng, Jianzhong},
title = {RETRACTED: The role of PKP1 in tumor progression in melanoma: Analysis of a cell adhesion‐related model},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24017}
}
EUVIMED